Fingerprint
Dive into the research topics of 'Phase i study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically